pillbase.ru

Firazyr

Active substance: icatibant

icatibant

Centralised EU authorisationActive

Marketing holder: Takeda Pharmaceuticals International AG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 9
  • Firazyr
    INJECTION, SOLUTION · ICATIBANT ACETATE 30 mg/3mL
    54092-702
    Takeda Pharmaceuticals America, Inc.
  • ICATIBANT
    INJECTION · ICATIBANT ACETATE 30 mg/3mL
    69097-664
    Cipla USA Inc.
  • Icatibant
    INJECTION, SOLUTION · ICATIBANT ACETATE 30 mg/3mL
    24201-207
    Hikma Pharmaceuticals USA Inc.
  • Icatibant
    INJECTION, SOLUTION · ICATIBANT ACETATE 30 mg/3mL
    55150-351
    Eugia US LLC
  • Icatibant
    INJECTION · ICATIBANT ACETATE 30 mg/3mL
    62332-654
    Alembic Pharmaceuticals Inc.
All products in this country (9)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4d21-7ada-9c1a-f499e792ab3a,01a1208c-74e5-7675-8f35-9ebf7ea53a40,01a1208c-abf9-7e6c-806b-e81027ac8659,01a1208d-428b-7e98-a2b0-f5f8d0541075,01a1208e-9c6d-7130-a9d9-79257963078d;count=9 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000899
Registration status
Active
ATC code
B06AC02
Sources
  • product · EMA · EMEA/H/C/000899 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000899 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000899 · Verified 2026-10-09